Upstart and Blue Owl Partner on $2 Billion Consumer Credit Agreement

New York, October 11, 2024 - PRISM MediaWire - Upstart (Nasdaq: UPST), an AI-driven lending marketplace, has announced a significant loan purchase agreement with funds managed by Blue Owl Capital. Under the terms of the deal, Blue Owl’s Alternative Credit strategy will a...
Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit

PITTSBURGH, Oct. 09, 2024 - PRISM MediaWire - Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman,...
SKYX Provides Corporate Update

MIAMI, Oct. 09, 2024 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with ...
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to  Atezolizumab in Phase 2 Clinical Trial

· Results published in peer-reviewed journal, Clinical Cancer Research
Sono-Tek Announces Fiscal Second Quarter and First Half 2025 Earnings Conference Call

Conference Call on Tuesday, October 15, 2024 at 10:00 am ET
SKYX Secures $11 Million Strategic Investment at $2.00 Per Share, Preferred Stock Convertible, Led by Global Marriott Hotel-Chain Developer, Lance Shaner, Owner of over 60 Hotels, Primarily Marriotts

SKYX Secures $11 Million Strategic Investment at $2.00 Per Share, Preferred Stock Convertible, Led by Global Marriott Hotel-Chain Developer, Lance Shaner, Owner of over 60 Hotels, Primarily Marriotts
AmpliTech Group Announces Receipt of Notice of Allowance for Patents in 5G and Cryogenic Technology For Quantum Computing Applications

Hauppauge, NY, October 7, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the...
IONQ Achieves Important Achievement Progressing Ion-Ion Entanglement

New York, October 04, 2024 - PRISM MediaWire - IonQ, (NYSE: IONQ) a leading player in the quantum computing industry, has reached a major milestone on its path to scaling quantum systems by demonstrating remote ion-ion entanglement. Building on the ion-photon entanglemen...
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories
SPZI: JP 3E Holdings, Inc. Accelerates Growth with Major Corporate Milestones Toward Uplisting

NEW YORK, October 14, 2024 - PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., is excited to announce a series of significant corporate developments that mark a new era of growth and expansion for the company. These strategic initiatives include s...
Upstart and Blue Owl Partner on $2 Billion Consumer Credit Agreement

New York, October 11, 2024 - PRISM MediaWire - Upstart (Nasdaq: UPST), an AI-driven lending marketplace, has announced a significant loan purchase agreement with funds managed by Blue Owl Capital. Under the terms of the deal, Blue Owl’s Alternative Credit strategy will a...
Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit

PITTSBURGH, Oct. 09, 2024 - PRISM MediaWire - Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman,...
SKYX Provides Corporate Update

MIAMI, Oct. 09, 2024 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with ...
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to  Atezolizumab in Phase 2 Clinical Trial

· Results published in peer-reviewed journal, Clinical Cancer Research
Sono-Tek Announces Fiscal Second Quarter and First Half 2025 Earnings Conference Call

Conference Call on Tuesday, October 15, 2024 at 10:00 am ET
SKYX Secures $11 Million Strategic Investment at $2.00 Per Share, Preferred Stock Convertible, Led by Global Marriott Hotel-Chain Developer, Lance Shaner, Owner of over 60 Hotels, Primarily Marriotts

SKYX Secures $11 Million Strategic Investment at $2.00 Per Share, Preferred Stock Convertible, Led by Global Marriott Hotel-Chain Developer, Lance Shaner, Owner of over 60 Hotels, Primarily Marriotts
AmpliTech Group Announces Receipt of Notice of Allowance for Patents in 5G and Cryogenic Technology For Quantum Computing Applications

Hauppauge, NY, October 7, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the...
IONQ Achieves Important Achievement Progressing Ion-Ion Entanglement

New York, October 04, 2024 - PRISM MediaWire - IonQ, (NYSE: IONQ) a leading player in the quantum computing industry, has reached a major milestone on its path to scaling quantum systems by demonstrating remote ion-ion entanglement. Building on the ion-photon entanglemen...
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories

Subscribe

Let's stay in touch!
1
2
3
4
5
6
7
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.